Opportunities for the treatment of atherosclerosis: Selectins

Opportunities for the treatment of atherosclerosis: Selectins

Despite the widespread availability of selectins for tumor therapy, their contribution to atherosclerosis has long been under-emphasized due to their “cofactor’s” status and technological limitations. However, advances in immunohistology, glycomics, and related technologies require us to reassess th...

Full description

Saved in:
Bibliographic Details
Main Authors: Nong Li, Chao Pi, Siying Zhu, Xiumei Li, Liu Wang, Peng Shi, Ying Zuo, Wenwu Zheng, Jun Jiang, Yan Yang, Qiong Zhang, Lei Tao, Shifeng Chu, Yumeng Wei, Ling Zhao
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Pharmacological Research
Subjects:
Selectins
Atherosclerosis
Translational medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661825002324
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items